Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pihlajalinna OyjFRA:38P +0.56%71 3-Year EBITDA Growth Rate is 26.90% as of Jun. 2026, which is 113% above its 10-year median of 12.60. GuruFocus rates FRA:38P with a GF Score™ of 71/100 and a GF Value™ of €9.50 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 524 Healthcare Providers & Services companies, Pihlajalinna Oyj ranks better than 75.19% on this metric.
During the past 12 months, Pihlajalinna Oyj's average EBITDA Per Share Growth Rate was -17.90% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 26.90% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 17.00% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 17.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Pihlajalinna Oyj was 45.00% per year. The lowest was 4.30% per year. And the median was 12.60% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Pihlajalinna Oyj 3-Year EBITDA Growth Rate Related Terms
FRA:38P vs HCA, THC, EHC: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Pihlajalinna Oyj's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pihlajalinna Oyj 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pihlajalinna Oyj's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Pihlajalinna Oyj's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 26.90% mean?
Pihlajalinna Oyj (FRA:38P) has a 3-Year EBITDA Growth Rate of 26.90% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Pihlajalinna Oyj and its competitors. This is 113% above median its historical median of 12.60. Over the past decade, Pihlajalinna Oyj's 3-Year EBITDA Growth Rate has ranged from 4.30 to 45.00. According to the industry distribution chart, Pihlajalinna Oyj ranks #130 out of 524 companies in the Healthcare Providers & Services industry, placing it in the top 24.8%.
Is Pihlajalinna Oyj's 3-Year EBITDA Growth Rate too high?
Pihlajalinna Oyj's current 3-Year EBITDA Growth Rate of 26.90% is 113% above median its 10-year median of 12.60. Over the past 10 years, this metric has ranged from a low of 4.30 to a high of 45.00. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 9.90. Pihlajalinna Oyj's value of 26.90% is 171.7% above this industry median. Based on the distribution chart, Pihlajalinna Oyj ranks #130 out of 524 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pihlajalinna Oyj has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pihlajalinna Oyj's 3-Year EBITDA Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Pihlajalinna Oyj ranks #130 out of 524 companies for 3-Year EBITDA Growth Rate. This places Pihlajalinna Oyj in the top 25% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 9.90. Pihlajalinna Oyj's value of 26.90% is 171.7% above this benchmark. Historically, Pihlajalinna Oyj's own 3-Year EBITDA Growth Rate has ranged from 4.30 to 45.00 over the past decade. While the company's 10-year median is 12.60 vs. the industry median of 9.90, Pihlajalinna Oyj has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 9.90, based on 524 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pihlajalinna Oyj's current 3-Year EBITDA Growth Rate of 26.90% is 171.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Pihlajalinna Oyj and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 9.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pihlajalinna Oyj's current 3-Year EBITDA Growth Rate is 26.90%, which is 113% above median its own 10-year median of 12.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pihlajalinna Oyj stock overvalued right now?
Based on GuruFocus' analysis, Pihlajalinna Oyj (FRA:38P) is currently considered Modestly Overvalued. The stock's GF Value™ is €9.50, compared to a current price of €10.86 — trading 14.3% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 26.90%, which is 113% above median its 10-year median of 12.60 and 171.7% above the Healthcare Providers & Services industry median of 9.90. Pihlajalinna Oyj's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Pihlajalinna Oyj (FRA:38P), the current 3-Year EBITDA Growth Rate is 26.90% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pihlajalinna Oyj (FRA:38P) Overvalued in 2026?
Based on GuruFocus' analysis, Pihlajalinna Oyj stock appears to be overvalued.
The current stock price of €10.86 is trading 14.3% above its estimated GF Value™ of €9.50.
GuruFocus considers Pihlajalinna Oyj to be Modestly Overvalued.
Key valuation signals for FRA:38P:
3-Year EBITDA Growth Rate: 26.90% (113% above median its 10-year median of 12.60)
GF Value™: €9.50 vs. price of €10.86 (14.3% above fair value)
Industry Position: 171.7% above the Healthcare Providers & Services median (#130 of 524)
No single metric tells the full story. See the FRA:38P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pihlajalinna Oyj is a private social and healthcare service providers in Finland. It provides comprehensive, high-quality services through private clinics, hospitals, remote channels, occupational healthcare, and tailored social and healthcare solutions for the public sector. It has two reportable segments: Private Healthcare Services and Public Services. The Private Healthcare Services operating segment consists of private clinic, diagnostics, hospital, occupational healthcare, remote and fitness center services. The Public Services operating segment consists of social and healthcare services produced for the public sector, which include outsourcing and housing services, mainly remotely produced responsible doctor services, as well as a wide range of staffing and recruitment services.
71GF Score
Get the complete analysis for FRA:38P
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:38P has been successfully added to your 
